Paramount Cosmetics (India) Limited has successfully completed the sale of its Umarsadi, Pardi District, Valsad property to affiliate Paramount Kum Kum Private Limited on August 7, 2026. The transaction, which was approved by shareholders at an Extraordinary General Meeting held on February 13, 2026, was formally noted by the Board of Directors during their meeting on August 12, 2026. The company's Company Secretary and Compliance Officer, Ms. Prerna Jain, signed the communication submitted to BSE Limited in compliance with Sub-regulation (4) of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The sale to an affiliated entity implies that the asset remains within the broader corporate group, potentially optimizing tax efficiency or operational control without exiting the group ecosystem entirely.
According to latest reports, Paramount Cosmetics (India) has seen its investment rating upgraded from Strong Sell to Sell as of August 10, 2026, driven primarily by a positive shift in technical indicators despite persistent fundamental challenges. The company's Mojo Score now stands at 38.0, reflecting a cautious but slightly more optimistic outlook amid flat financial performance. Key technical signals include a bullish Moving Average Convergence Divergence (MACD) on the weekly chart and a mildly bullish MACD on the monthly chart, with the weekly Bollinger Bands signaling a bullish trend and the Know Sure Thing (KST) indicator showing mildly bullish momentum on both weekly and monthly timeframes.
According to reports from Business Standard, Paramount Cosmetics (India) reported a standalone net profit of ₹0.12 crore in the quarter ended June 2026, marking a significant turnaround from the net loss of ₹0.06 crore recorded in the corresponding quarter of the previous financial year. This represents a complete reversal in the company's profitability position year-over-year. However, the company's recent six-month net sales figure of ₹8.02 crores reflects a sharp contraction of 30.50%, signalling ongoing operational challenges despite the quarterly profitability.
As reported by Business Standard, the company's operating profit margin (OPM) improved to -10.71% in Q1 FY27 from -19.40% in the corresponding quarter of the previous year. Additionally, PBDT increased 25% to ₹0.15 crore and PBT surged 500% to ₹0.06 crore compared to the previous year's quarter. However, the company continues to face significant operational challenges, with operating profits declining at a compounded annual growth rate (CAGR) of -7.13% over the past five years and average Return on Equity (ROE) remaining critically low at 0.52%. The company's ability to service its debt is notably poor, with an average EBIT to interest coverage ratio of just 0.20.
Despite the technical upgrade and property sale completion, Paramount Cosmetics trades at a Price to Book (P/B) ratio of 0.9, which is considered expensive given the company's low ROE of 0.2%. The stock's Price/Earnings to Growth (PEG) ratio is 2.6, indicating that the stock is overvalued relative to its earnings growth prospects. Over the past year, the stock has delivered a negative return of -4.98%, underperforming the Sensex's -1.65% return and the BSE500 index consistently over the last three years. The company's 52-week high is ₹48.85 and low is ₹30.70, indicating a wide trading range with today's intraday range between ₹38.00 and ₹39.50.
